Home/Filings/4/0001062993-25-007136
4//SEC Filing

Bohnen Shane 4

Accession 0001062993-25-007136

CIK 0000842023other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:25 PM ET

Size

24.1 KB

Accession

0001062993-25-007136

Insider Transaction Report

Form 4
Period: 2025-04-03
Bohnen Shane
SVP - General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-03+2,2603,941 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-04-032,2602,259 total
    Common Stock (2,260 underlying)
  • Tax Payment

    Common Stock

    2025-04-03$54.86/sh747$40,9803,194 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $66.97Exp: 2027-08-05Common Stock (8,944 underlying)
    8,944
  • Stock Option (Right to Buy)

    Exercise: $120.46Exp: 2028-08-06Common Stock (3,460 underlying)
    3,460
  • Restricted Stock Units

    Common Stock (99 underlying)
    99
  • Performance Stock Option (Right to Buy)

    Exercise: $84.61Common Stock (12,924 underlying)
    12,924
  • Performance Restricted Stock Units

    Common Stock (10,012 underlying)
    10,012
  • Restricted Stock Units

    Common Stock (5,006 underlying)
    5,006
  • Stock Option (Right to Buy)

    Exercise: $84.61Exp: 2030-08-15Common Stock (16,302 underlying)
    16,302
  • Stock Option (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (3,508 underlying)
    3,508
  • Performance Restricted Stock Units

    Common Stock (4,802 underlying)
    4,802
  • Stock Option (Right to Buy)

    Exercise: $47.60Exp: 2026-08-07Common Stock (8,848 underlying)
    8,848
  • Stock Option (Right to Buy)

    Exercise: $73.76Exp: 2030-04-03Common Stock (3,928 underlying)
    3,928
  • Stock Option (Right to Buy)

    Exercise: $74.91Exp: 2034-08-15Common Stock (13,488 underlying)
    13,488
Footnotes (12)
  • [F1]Fully exercisable.
  • [F10]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F11]1,668 restricted stock units vest on 8/15/2025, and 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
  • [F12]Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
  • [F2]Options to purchase 864 shares vest on each of 8/6/2022, 8/6/2024 and 8/6/2025, and options to purchase 868 shares vest on 8/6/2023.
  • [F3]Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
  • [F4]Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F6]2,259 restricted stock units vest on 4/3/2026.
  • [F7]Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
  • [F8]50 restricted stock units vest on 8/15/2025, and 49 restricted stock units vest on 8/15/2026.
  • [F9]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001969581

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:25 PM ET
Size
24.1 KB